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DpsC co-crystal  
with 4 
 
PDB ID: 5TT4 4XS7 4XSA 4XSB 4XS9 
Crystallization 0.18 M sodium citrate, 26 % PEG 
3350 
0.18 M sodium 
citrate, 26 % PEG 
3350 
0.18 M sodium 
citrate, 26 % PEG 
3350 
0.18 M sodium 
citrate, 26 % PEG 
3350 
0.18 M sodium 
citrate, 26 % PEG 
3350 
Crystallographic 
Data 
     
Wavelength (Å) 0.9999 0.9775 1.0000 0.9999 0.9795 
Space Group P6522 P6522 P6522 P6522 P6522 
Cell Dimension       
a, b, c (Å) 
90.033, 90.033, 
304.689 
91.213, 91.213, 
315.643 
91.477, 91.477, 
316.833 
91.382, 91.382, 
315.783 
89.702, 89.702, 
302.704 
 α=β=90°, γ=120° α=β=90°, γ=120° α=β=90°, γ=120° α=β=90°, γ=120° α=β=90°, γ=120° 
Resolution (Å) 50.00 - 2.50 50.00-2.40 50.00 - 2.40 50.00 - 2.20 50.00-2.30 
No. of observations 557086 500940 857439 411366 479239 
No. of unique 
observations 
26403 31516 40753 40709 33191 
Completeness %  99.3 (98.8) 100.00 (100.00) 99.6 (99.2) 99.9 (100) 100.0 (100.0) 
I/σ(I)  24.1 (6.0) 18.6 (4.3) 25.0 (5.3) 18.4 (2.6) 19.8 (6.0) 
Rmerge % 14.2 (65.0) 13.9 (79.9) 16.5 (75.9) 11.3 (81.9) 17.8 (44.3) 
Redundancy 21.1 15.9 22.5 10.1 14.4 
Refinement      
Resolution (Å) 50.00 - 2.50 (2.59 - 
2.50) 
50.00 - 2.40 (2.49 - 
2.40) 
50.00 - 2.4 (2.49 - 
2.40) 
50.00 - 2.20 (2.28 - 
2.20) 
50.00 - 2.30 (2.38 - 
2.30) 
No. of protein atoms 5058 5068 5102 5104 5073 
No. of ligand atoms 0 0 0 0 52 
No. of water atoms 173 248 572 431 316 
Rfree % 20.88 (23.47) 21.57 (29.88) 20.29 (24.10) 22.49 (31.98) 19.76 (23.02) 
Rcrys % 16.18 (18.96) 17.70 (20.80) 16.64 (18.10) 17.79 (25.03) 15.93 (17.81) 
Geometry      
RMS bonds (Å) 0.008 0.023 0.009 0.008 0.008 
RMS angles (°) 1.09 1.40 1.17 1.16 1.10 
Ramachandran 
Favored (%) 
98.00 96.00 97.00 96.00 98.00 
Ramachandran 
Allowed (%) 
1.55 3.55 2.56 3.41 1.70 
Ramachandran 
Dissallowed (%) 
0.45 0.45 0.44 0.59 0.30 
Average B-factors 
(Å2) 
     
Protein 32.40 34.30 17.50 29.90 29.00 
Water 33.80 35.30 26.40 35.70 40.20 
Ligands N/A N/A N/A N/A 33.10 
 
Table S1. DpsC crystallographic data collection and refinement statistics.  
*Numbers in parentheses denote the highest resolution shell.  
 
 
 
	
	
Figure S1. DpsC self-acylation with different acyl-CoA substrates. (A) 
Deconvolved ESI-MS spectra of purified DpsC after incubation with different CoA 
derivatives (acetyl-CoA, propionyl-CoA, butyryl-CoA and malonyl-CoA). ESI-MS 
analysis indicated that DpsC does not selectively load propionate. Calculated 
masses of DpsC, acetyl-DpsC, propionyl-DpsC, butyryl-DpsC and malonyl-DpsC 
are 39248, 39287, 39304, 39315 and 39334 Da respectively. (B) Graph showing 
the self-acylation efficiency of DpsC towards different starter units in non-
saturating conditions. Higher affinity for propionate was not observed.  
 
 	
Figure S2. In vitro kinetic assay of DpsC self-acylation. (A) Schematic representation 
of the mechanism of KDH assay and Michaelis-Menten plots for the self- acylation of 
DpsC. (B) Kinetic parameters were calculated by fitting the Michaelis-Menten curve 
to the experimental data.  
  	
  
										 		
		 	
Figure S3. In vitro assays for DpsC acyl-transfer to DpsG. (A) Deconvolved ESI-MS 
spectrum showing acyltransferase activity of DpsC when incubated with holo-DpsG 
and CoA derivatives. Calculated masses for holo-, acetyl-, propionyl- and butyryl-
DpsG are 9604, 9646, 9660 and 9674 Da respectively. (B) The rate of conversion of 
holo-DpsG to the acylated form for all starter units. (C) Deconvolved ESI-MS 
spectrum of holo-DpsG components from acyltransferase activity by DpsC. No 
selective transfer of propionate onto DpsG was observed when the enzymes were 
incubated in a pool of different starter units.  
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Figure S4. The differences in spatial orientation between the DpsC and EcFabH 
active site residues. (A) In DpsC, Ser118, His297, and Asp302, are located on L5, 
L12, and Cα3, respectively. (B) In EcFabH, Cys112, His244, and Asn274, are located 
on L5, L12, and L11, respectively. (C) His297 and Asp302 of DpsC are behind the 
active site pocket and His297 is positioned so that the aromatic ring stacks against 
the side of the pocket. (D) His244 and Asn274 of EcFabH are positioned to the side 
of the active site pocket with both of their side chains able to form hydrogen bonds 
with substrates in the active site. 
  
  
	
Figure S5. SA omit maps of the DpsC active site. The active site of monomer A is 
on the left (residues labeled) and the active site of monomer B is on the right 
(residues unlabeled). Acyl groups are colored in cyan. (A) Apo-DpsC. (B) Acetyl-
DpsC. (C) Propionyl-DpsC. (D) Butyryl-DpsC.  
  
	
Figure S6. Comparison of the DpsC active site with the EcFabH active site 
focusing on Leu93 (DpsC) and Phe87 (EcFabH). 
 
 
 
 
  
	
Figure S7. Synthesis of the phosphorylated PPant analogue 4. Protected 
pantetheine amine 1 can be coupled with a propanoic acid, and deprotection yields 
the pantetheine analogue 3 with an amide linkage. 3 can be directly phosphorylated 
using the CoaA kinase to form a substrate mimic 4 for co-crystallization.  
 									 	
Figure S8. Sequence alignment of putative DpsC homologues. The active site 
residues are marked with a red dot and residues in the acyl binding region are 
marked with a blue dot. 
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